Vascular Biogenics (NASDAQ:VBLT) Research Coverage Started at StockNews.com

Equities research analysts at StockNews.com initiated coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a report released on Saturday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. A number of other equities research analysts have also issued reports on the company. HC Wainwright lowered Vascular Biogenics from a “buy” […]